差异性素乙化和超增强剂调节是黑色素瘤细胞脱差的基础
Karen Mendelson1, Tiphaine C Martin2,3, Christie B Nguyen2,3,4
1Department of Dermatology, NYU Grossman School of Medicine, New York, New York, USA.
黑色素瘤细胞从增殖转变为侵入性状态,通过122个基因的表观遗传特征 (Epgn1/Epgn3) 来识别. 这种表型切换涉及染色质变化和超强增强剂,提供潜在的治疗点.
科学领域:
- 黑色素瘤研究研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 脱差异化或表型切换描述了细胞从增殖到入侵的转变.
- 一个122基因的表观遗传特征 (Epgn1用于低风险,Epgn3用于高风险) 之前被确定来分类初级黑色素瘤.
- Epgn1和Epgn3细胞的转录组分别类似于增殖和侵入性状态,并在瘤样本中得到验证.
研究的目的:
- 为了研究低风险 (Epgn1) 和高风险 (Epgn3) 黑色素瘤细胞之间的染色体景观差异.
- 了解超级增强剂和增强剂在黑色素瘤表型切换中的作用.
- 确定驱动黑色素瘤进展的关键基因和调控机制.
主要方法:
- 染色体景观的分析,包括H3K27乙化.
- 在Epgn1和Epgn3细胞中识别和比较超级增强剂和增强剂景观.
- 对ITGA3.3的基因表达分析和功能研究 (基因沉默)
主要成果:
- 在Epgn1和Epgn3细胞之间观察到不同的H3K27乙化和增强剂景观.
- 黑色细胞系基因 (MITF) 与Epgn1细胞中的超级增强剂有关,而侵入性基因与Epgn3状态有关.
- 标志着Epgn3细胞中的超级增强剂ITGA3,被确定为黑色素瘤入侵的负调节者,因为沉默ITGA3增强了入侵性.
结论:
- 由超级增强剂和增强剂驱动的染色体格局变化与黑色素瘤中的Epgn1/Epgn3特征和表型切换有关.
- 这些表观遗传机制调节了早期黑色素瘤进展期间的转录重编程.
- 已确定的超强增强剂驱动的表观遗传调节网络为黑色素瘤治疗提供了潜在的点.
更多相关视频
11:02Complete Workflow for Analysis of Histone Post-translational Modifications Using Bottom-up Mass Spectrometry: From Histone Extraction to Data Analysis
Published on: May 17, 2016
10:09Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
相关概念视频
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Spreading of Chromatin Modifications
Writers
The writer...
Histone Variants at the Centromere
Inheritance of Chromatin Structures
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
